Semaphorin 3c variants, compositions comprising said variants and methods of use thereof
US2015290285A1
Light-sensitive ion channels for induction of cardiac activity
EP2914299A1
Light-sensitive pumps for suppression of cardiac activity
WO2012160559A1
Pharmaceutical compositions of d-alpha-tocopheryl acetate
IL218580D0
Methods for diagnosing an inflammatory disease
WO2012114339A1
High affinity molecules capable of binding a type a plexin receptor and uses of same
IL217161D0
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
WO2012025925A1
Methods of improving transplantation using sdf-1alpha
WO2011138785A2
Use of ccl1 in therapy
AU2010264072A1
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
IL205924D0
Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
IL205463D0
Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2 -2
IL205061D0
Compositions comprising pro-protein convertase resistant semaphorins 3d, 3e and 3g for the treatment of angiogenesis related diseases and methods of selection thereof
WO2010103517A1
Soluble compositions for the treatment of cxcr3-ligand associated diseases
IL202502D0
Cxcl11 for the treatment of inflammatory diseases
IL200296D0
Agents for the treatment of multiple sclerosis and methods of using same
EP2318439A2
Methods of altering peripheral b cell populations and uses thereof
EP2220208A2
Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
